DK125595B - Analogifremgangsmåde til fremstilling af et 2-(4'-hydroxy-benzoyl)-benzoesurt salt af 3-(β,β-diphenylethyl)-5-(βpiperidionethyl)-1,2,4-oxadiazol.
- Google Patents
Analogifremgangsmåde til fremstilling af et 2-(4'-hydroxy-benzoyl)-benzoesurt salt af 3-(β,β-diphenylethyl)-5-(βpiperidionethyl)-1,2,4-oxadiazol.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es VegyeszetfiledCriticalChinoin Gyogyszer Es Vegyeszet
Publication of DK125595BpublicationCriticalpatent/DK125595B/da
C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Compressor
(AREA)
DK573771A1970-11-271971-11-23Analogifremgangsmåde til fremstilling af et 2-(4'-hydroxy-benzoyl)-benzoesurt salt af 3-(β,β-diphenylethyl)-5-(βpiperidionethyl)-1,2,4-oxadiazol.
DK125595B
(da)
Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydro-4-phenyl-isoquinolinderivater eller syreadditionssalte deraf eller de tilsvarende optisk aktive forbindelser.
Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 3,5-disubstituerede fenylætanolaminforbindelser eller terapeutisk acceptable syreadditionssalte deraf.
Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 2-(4,4'-dihalo)-benzhydryl-3-quinuclidinoler eller syreadditionssalte deraf.
Analogifremgangsmåde til fremstilling af antirhinovirale 2,5-bis-substituerede amino-1,3,4,-thiadiazoler eller farmaceutisk acceptable syreadditionssalte deraf.